Search
Close this search box.
Search
Close this search box.

September 22, 2025

Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset

Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong Kong, Macau and Taiwan Sovargen receives upfront payment and is eligible for future milestone-dependent payments and

Coventry célèbre la puissance, la flexibilité et la valeur de l’assurance-vie pendant le Mois de la sensibilisation à l’assurance-vie

FORT WASHINGTON, Pennsylvanie, 22 sept. 2025 (GLOBE NEWSWIRE) — Coventry, leader et fondateur du marché secondaire de lʼassurance-vie, est fier de célébrer le Mois de la sensibilisation à lʼassurance-vie en réaffirmant son engagement indéfectible à faire de lʼassurance-vie non seulement un actif essentiel, mais également un produit plus précieux, plus

Axi Announces Retirement of Chief Commercial Officer Louis Cooper

Louis Cooper Chief Commercial Officer Axi ( CCO) Louis Cooper Chief Commercial Officer Axi ( CCO) SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a leading global online trading and fintech company, today announces the retirement of Louis Cooper, Chief Commercial Officer. Louis will formally step down from his executive

OPEC Fund mobilizes over US$1 billion to advance sustainable development

Governing Board approves major financing package as institution launches inaugural Euro benchmark bond OPEC Fund President Abdulhamid Alkhalifa OPEC Fund President Abdulhamid Alkhalifa VIENNA, Sept. 22, 2025 (GLOBE NEWSWIRE) — The OPEC Fund for International Development (the OPEC Fund) announced the approval of more than US$1 billion in new development

Recent Posts